Worlds Inc. Implements a 5 to 1 Reverse Split
09 févr. 2018 14h30 HE
|
Worlds Inc.
BOSTON, Feb. 09, 2018 (GLOBE NEWSWIRE) -- Worlds Inc. (OTCQB:WDDD) has implemented a 5 to 1 reverse stock split of the Company’s common shares, effective February 9, 2018, to facilitate the recently...
Wrinkl Granted Three Patents for its Group Messaging Platform
05 févr. 2018 09h00 HE
|
Wrinkl
PHILADELPHIA, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Wrinkl, the actionable group messaging platform that brings clarity and productivity back to collaboration, today announced the company was granted...
Worlds Inc. Investors Exercise Warrants For $875,000, Strengthen Ability to Pursue Infringers
30 janv. 2018 08h02 HE
|
Worlds Inc.
BOSTON, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Worlds Inc. (OTCQB:WDDD) investors have chosen to exercise their warrants per the terms of the funding of the Inter Partes Review (IPR) appeal as reported...
Digital Reasoning Allowed Significant Patent for Using Machine Learning in Electronic Communications Surveillance
25 janv. 2018 14h53 HE
|
Digital Reasoning Systems, Inc.
NASHVILLE, Tenn., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Digital Reasoning, a leader in Artificial Intelligence (AI) for understanding human communications, announced that the U.S. Patent and Trademark...
Galectin Therapeutics Granted Patents in China and Japan that Support NASH and Cancer Immunotherapy Clinical Development Programs
25 janv. 2018 08h30 HE
|
Galectin Therapeutics Inc.
NORCROSS, Ga., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins to treat non-alcoholic steatohepatitis...
Court Date Set for Worlds Inc.’s IPR Appeal Oral Argument
25 janv. 2018 08h00 HE
|
Worlds Inc.
BOSTON, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Worlds Inc. (OTCQB:WDDD) announced that on January 22, 2018, the United States Court of Appeals for the Federal Circuit scheduled the oral argument for...
Amarantus Subsidiary Cutanogen Corporation Announces Issuance of US Patent 14/299,480 Covering ESS, Pigmented ESS and Gene Therapy-Modified ESS
23 janv. 2018 09h59 HE
|
Amarantus Bioscience Holdings, Inc.
Patent Issuance Opens Potential to genetically modify cells used to produce ESS Peer-Reviewed publication demonstrates improved donor cosmetic skin color matching of melanocytes-implanted ESS vs....
Mattersight Issued Four New Patents Signaling the Future of Analytics
09 janv. 2018 10h45 HE
|
Mattersight Corporation
CHICAGO, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Mattersight Corporation (NASDAQ:MATR), the pioneer in personality-based software applications, announced today that the USPTO recently granted four new...
London Court of Appeal Validates IPCom’s Mobile Telecoms Patent Critical to the UMTS Standard
09 janv. 2018 08h00 HE
|
IPCom GmBH & Co. KG
MUNICH, Germany, Jan. 09, 2018 (GLOBE NEWSWIRE) -- IPCom, a leading patent licensing entity with a global portfolio of mobile telecommunications patents, today announced that, earlier in 2017, the...
Amarantus Subsidiary Cutanogen Corporation Announces Patent Issuance in Hong Kong Covering ESS, Pigmented ESS and Gene Therapy-Modified ESS
04 janv. 2018 09h45 HE
|
Amarantus Bioscience Holdings, Inc.
Patent Issuance Opens Potential to genetically modify cells used to produce ESSPeer-Reviewed publication demonstrates improved donor cosmetic skin color matching of melanocytes-implanted ESS vs....